ACAD: Acadia Pharmaceuticals Inc.
Performance
ACAD -26.89%
Watchlist
Select an item
Summary
ACAD at a glance
ACAD returned -26.89% over the past year and -3.78% a year over five years. Its worst drop in that year was -46.03%, smaller than 28% of stocks on Redstone, and its Sharpe ratio of -0.56 beats 11% of stocks on Redstone. It pays no dividends.
Current Drawdown
-46.03%
Rolling Volatility
84.64%
Actions
Metrics
Risk Indicators
Alpha-28.25%
Beta0.35x
Sharpe-0.56
Sortino-0.70
Omega0.90
Calmar-0.58
Martin-1.31
Profile
About ACAD
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $2.8B
- Listed
- May 2004
- Employees
- 798
- Headquarters
- San Diego, CA
- Website
- acadia.com
Comparisons